Yüklüyor......
Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
Primary biliary cholangitis (PBC) is an autoimmune liver disease associated with altered lipoprotein metabolism, mainly cholesterol. Hypercholesterolaemia, a major modifiable risk factor for cardiovascular disease in the general population, occurs in 75%–95% of individuals with PBC. The impact of hy...
Kaydedildi:
| Yayımlandı: | Frontline Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788128/ https://ncbi.nlm.nih.gov/pubmed/31656566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101124 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|